about
Non-invasive diagnosis of liver fibrosis in chronic hepatitis CSerum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.To screen or not to screen? Celiac antibodies in liver diseases.Central nervous system vasculitis and polyneuropathy as first manifestations of hepatitis CDiagnostic Performance of Two Point-of-Care Tests for Anti-HCV Detection.Significance of alanine aminotransferase levels in patients admitted for cocaine intoxication.From stable disease to acute-on-chronic liver failure: Circulating cytokines are related to prognosis in different stages of cirrhosis.Bilateral adrenal histoplasmosis in an immunocompetent man.Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis.Positive serology for viral hepatitis and donor self-exclusion in Southern Brazil.Prevalence and factors associated with HCV infection among elderly individuals in a southern Brazilian city.Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?Anti-HCV reactive blood donors: clinical and epidemiological factors associated with false-reactive results.Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.Evidence of a significant role for Fas-mediated apoptosis in HCV clearance during pegylated interferon plus ribavirin combination therapy.Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index.Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C.YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.Anti-hepatitis C virus-positive blood donors: are women any different?Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients.Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.PROGNOSTIC FACTORS IN PATIENTS WITH PRESSURE SORES IN A UNIVERSITY HOSPITAL IN SOUTHERN BRAZIL.Recurrent anaemia in a patient with lymphocytic gastritis and vitamin B12 deficiency.Green sweat: an atypical finding in drug-induced liver disease.Gender influence on treatment of chronic hepatitis C genotype 1.Clinical and laboratorial features of spontaneous bacterial peritonitis in southern Brazil.Breast reconstruction after mastectomy for breast cancer: comparative analysis of early and delayed reconstruction.Autoantibody profile in individuals with chronic hepatitis C.HbA1c Levels as a Parameter of Glycemic Control in Patients with Liver Diseases.An unusual cause of ascites: Strongyloides stercoralis.The γ-glutamyl transpeptidase to platelet ratio (GPR) in HBV patients: just adding up?Benefits of beta-blockers for patients with cirrhosis and infection: do not celebrate too soon!Single-centre validation of the EASL-CLIF Consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosisLate-onset systemic lupus erythematosus-associated liver diseaseClinical and epidemiological profile of blood donors with positive serology for viral hepatitis in southern BrazilEpidemiologia da infecção pelo vírus da hepatite CImpact of CD4+ T-cell count on the performance of non-invasive fibrosis markers in HIV-HCV patientsExpanding the applicability of noninvasive fibrosis markers in HIV/HCV co-infected patientsClinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis
P50
Q26865956-24B3F874-89B8-4C13-B06C-00AB98D7F174Q33379616-F90413FC-1365-4D49-9C86-0DCF6C5A2701Q34551744-8627A0EA-D385-4ED1-ADCB-61D9594D40B2Q35670470-AC6B6E5B-B830-4B3A-A712-0012C223CAF3Q37315188-D4FCEDB4-A445-4500-852C-08870A1A99B5Q38187319-B165B750-DFBF-4F4B-BADC-525475090265Q40373959-019D1171-4716-487F-BA0E-78BF94185AFFQ40447198-850DAE52-D2D9-4815-9498-8FD6E435DCB4Q40520313-97E60659-AF4E-400B-BEB9-1632C2FA675CQ42273881-D69BA90F-BE72-484B-B33A-0F507273E90DQ42283670-AF7B966C-709C-4B7C-B70F-E724077C2532Q42976785-99A68C90-18A0-4F78-ACCF-B65CA51B17F9Q42976785-F35EC263-8E08-4082-AF94-20405E157379Q42983484-AF8B90D1-9BBB-45C5-9382-50AFE117C1BBQ43035620-36104ACA-3726-4DAD-A4AD-B846B265402BQ43036619-4A92E933-55E1-4C49-9A2D-DEA97C477008Q43275844-6BF89501-0C2F-424C-B398-B185F01F650BQ44156126-CC988314-67C4-47DA-B9B9-20CF933E4DFDQ44809014-00DE77EC-4C1D-47F5-BD37-F9E5EFD681B8Q45394018-98CB2A4A-0183-4043-AB1A-F179F5AC4B1CQ45394669-5F86AF59-2155-4ACF-8625-A8052A24A7F0Q45396508-83D36175-A957-4F23-B17E-79FF8ECC3645Q47951027-133B9617-5E11-4660-B6E1-AB5223E85A9EQ49632978-7F0CD658-B4DF-49C5-A3BE-53F66F2D8889Q49886019-8F8D34EF-AE61-47F0-886B-B864BDC1843DQ50464970-58815FF9-A934-4432-A2E0-6DD1803BC61FQ50559457-AAE49661-237F-4B90-80E2-E60F98951F25Q50653662-50B2E364-6E8A-4D97-9253-EFA65043987FQ50892863-0EAEDEF2-3ECB-4636-B44F-D4AD2435C24EQ50933723-6762F9A7-D6BE-4277-B4B8-16D883003FDBQ51046329-EABA55CE-2280-490E-9B8A-2D7B9AE1A1F6Q52760740-E61E574C-2703-4B9D-A651-24EE14FAA7A7Q52853855-56F83551-4DDC-465B-A523-D926AD4351EDQ61409608-EA184A99-B4E5-4F94-9E3C-C334A435E220Q61409614-5246896B-D0C9-45AF-B102-B85040557F45Q61409617-261D8F06-2D2E-4FDA-8770-B700CA4E1349Q61409618-748338D7-2C2C-4484-9059-93E4B92971BAQ61409619-EBD9F1EF-658F-4430-ABD7-73F52FA2DC08Q61409621-99C35BD4-9551-4555-B2B1-603658D0D8B6Q61409628-DE5C96C5-E8CA-4EE1-8D9C-ACA08CDF88F3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Janaína L Narciso-Schiavon
@ast
Janaína L Narciso-Schiavon
@en
Janaína L Narciso-Schiavon
@es
Janaína L Narciso-Schiavon
@nl
Janaína L Narciso-Schiavon
@sl
type
label
Janaína L Narciso-Schiavon
@ast
Janaína L Narciso-Schiavon
@en
Janaína L Narciso-Schiavon
@es
Janaína L Narciso-Schiavon
@nl
Janaína L Narciso-Schiavon
@sl
prefLabel
Janaína L Narciso-Schiavon
@ast
Janaína L Narciso-Schiavon
@en
Janaína L Narciso-Schiavon
@es
Janaína L Narciso-Schiavon
@nl
Janaína L Narciso-Schiavon
@sl
P1053
A-1357-2014
P106
P21
P31
P3829
P3835
janaina-narciso-schiavon
P496
0000-0002-6228-4120